However, these results are tempered by a meta-analysis of both G-CSF and GM-CSF, demonstrating that while there was a quicker reversal of sepsis in patients who received therapy, there was no improvement in 28-day survival [76]. The gene discussed is CSF2; the disease is Sepsis.